The Texas Department of Insurance, Division of Workers' Compensation (DWC) Research and Evaluation Group released a report analyzing health care cost and utilization.
The report was based on data reported to the DWC as of January 2026 for claims with service dates from January 2020 through December 2025, and injury dates from January 2020 through December 2024. The report's findings offer key insights to guide clinical strategy and identify targeted intervention opportunities. The study covers both network and non-network claims across professional, hospital/institutional, dental, and pharmacy services.
Pharmacy service costs fell 15%, from $47.8 million to $40.5 million, alongside a 17% drop in claims with pharmacy services. The average cost per claim increased slightly, from $619 to $638. Lost-time claims made up $33 million of 2025 pharmacy costs, with an average cost per claim of almost $1,000.
Opioid costs fell more than 60%, from $6.1 million to $2.4 million, and the share of pharmacy claims receiving opioids dropped from 35% to 18%. In contrast, compound drug prescriptions more than quadrupled, from 112 to 490, with total costs rising from $42,000 to $356,000.
Total health care costs rose 4%, from $830 million to $864 million, driven by a 5% increase in total claims (241,000 to 253,000), while the average cost per claim remained stable at about $3,400. Total costs reached more than $958 million in 2024 before decreasing by $94 million in 2025.
Claims receiving professional services increased 5%, and the average cost per claim rose from about $2,000 to $2,300. Total professional costs increased $84 million (about 18%).
Advanced practice registered nurse (APRN) service costs nearly doubled, going from $20 million to $40 million, the largest increase among provider types, followed by physician assistant costs, which rose 84%, from $18 million to $33 million. Durable medical equipment (DME) was the only provider type with a cost decline, from $17 million to almost $15 million.
For service years 2020 to 2024, the total number of non-network claims increased 4%, from 132,000 to 138,000, with total costs rising 9%, and the average cost per claim rising 4%. Network claims increased 24%, from 109,000 to 135,000, and total costs increased 25%, while the network average cost per claim remained stable at about $3,200.
For injury years 2020 to 2024 (services within 12 months of injury), total costs rose 29%, from $599 million to $775 million, largely due to a 22% increase in claims. The average cost per claim increased 6%, from $3,400 to $3,620.
The full report also breaks down costs and utilization by claim type, provider type, service type, and drug group, with additional detail on N status, Schedule II, compound, and brand/generic drugs.






